Photo taken from Penn Medicine/LinkedIn
Aug 11, 2024, 10:17
Carl June about the potential of using CAR T therapy to treat glioblastoma – Penn Medicine
Penn Medicine shared a post on LinkedIn:
“This year could see major breakthroughs in brain cancer treatment.
Carl June, MD, the Richard W. Vague Professor in Immunotherapy, spoke about the potential of using CAR T therapy to treat glioblastoma, a rare and aggressive form of brain cancer that carries a median survival time of 15-18 months.
“I think about five years down the line, we’re going to have FDA-approved CARs for glioblastoma,” he said.”
Read the full interview.
Source: Penn Medicine /LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 7, 2024, 00:18
Nov 7, 2024, 00:04
Nov 6, 2024, 18:17